ArticleCureus2024
Determining the Mean Dermatology Life Quality Index of Skin of Color (SOC) Patients With Vitiligo: A South Asian Perspective.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitiligo has a special significance to the skin of colour (SOC) population because depigmentation is more obvious in the SOC population. As a result, vitiligo exerts a huge stigma on the affected individuals. The literature so far has reported on the health-related quality of life (QOL), including the dermatology life quality index (DLQI), and has demonstrated the profound effect of vitiligo on a patient's QOL. Those affected by vitiligo are found to have lower self-esteem when compared to the non-affected individuals. The impact on the SOC population is even graver and underrepresented. Thus, the objective of this study was to report the mean DLQI in vitiligo in SOC individuals. MATERIALS AND
methodsThis descriptive, cross-sectional study was performed in the dermatology outpatient department of a tertiary healthcare setup in Rawalpindi Pakistan. A total of 113 patients suffering from vitiligo, aged 15 to 65 years, both male and female, were included in the study. In all the cases, the DLQI score was noted.
resultsWith the age ranging from 15 to 65 years and a mean age of 34.96 ± 9.59 years, 70% (n=77) of the patients were between 15 to 40 years of age. The male-to-female ratio was 1:1.3, with male patients comprising 38.21% (n=47) and females being 61.79% (n=66). The mean DLQI score of the vitiligo patients in our cohort was 9.39 ± 6.35.
conclusionThis study concluded that the mean DLQI score was higher in female patients and in vitiligo universalis patients, compared to other variants of vitiligo. The SOC population affected with vitiligo is at a higher risk of having a decreased QOL and hence may need special attention with regard to quality health delivery services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.